December 4, 2018Open Access

Kabuki syndrome: international consensus diagnostic criteria

Key Points

Key points are not available for this paper at this time.

Abstract

As targeted therapies for KS are being developed, it is important to be able to make the correct diagnosis, either with or without molecular genetic confirmation.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Adam et al. (Tue,) studied this question.

synapsesocial.com/papers/69db469f3d9adb00e768488d https://doi.org/https://doi.org/10.1136/jmedgenet-2018-105625

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical and Neurobehavioral Features of Three Novel Kabuki Syndrome Patients with Mosaic KMT2D Mutations and a Review of Literature2017 · 26 citations
2Molecular, clinical and neuropsychological study in 31 patients with Kabuki syndrome and <i><scp>KMT2D</scp></i> mutations2017 · 44 citations
3Kabuki syndrome: clinical and molecular diagnosis in the first year of life2014 · 102 citations
4Molecular genetic analysis in 14 Czech Kabuki syndrome patients is confirming the utility of phenotypic scoring2016 · 23 citations
5A three generation X‐linked family with Kabuki syndrome phenotype and a frameshift mutation in <i>KDM6A</i>2014 · 47 citations

Bookmark

View Full Paper